SWM
AMED

Selective Wealth Management’s Amedisys AMED Stock Holding History

Selective Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12
Closed -$2K – 750
2022
Q1 		$2K Hold
12
– – ﹤0.01% 650
2021
Q4 		$2K Hold
12
– – ﹤0.01% 597
2021
Q3 		$2K Hold
12
– – ﹤0.01% 534
2021
Q2 		$3K Buy
+12
New +$3.15K ﹤0.01% 432

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Selective Wealth Management's AMED Position: Q2 2022 in Review

Selective Wealth Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 12 shares — an estimated $2K sold.

Selective Wealth Management first reported a position in AMED in Q2 2021 and held it in 4 quarters. The position peaked at $3K in Q2 2021. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Selective Wealth Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Selective Wealth Management sold 12 Amedisys shares in Q2 2022, an estimated $2K.
  • Selective Wealth Management first reported a position in Amedisys in Q2 2021 and held it in 4 quarters.
  • Selective Wealth Management's Amedisys position peaked at $3K in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Selective Wealth Management's 13F filing for Q2 2022, filed 28 Jul 2022.